Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
November 10 2022 - 4:35PM
Business Wire
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in
serving science, today announced that its board of directors has
authorized the repurchase of $4 billion of shares of its common
stock in the open market or in negotiated transactions. The
authorization has no expiration date.
About Thermo Fisher Scientific Thermo Fisher Scientific
Inc. is the world leader in serving science, with annual revenue of
approximately $40 billion. Our Mission is to enable our customers
to make the world healthier, cleaner and safer. Whether our
customers are accelerating life sciences research, solving complex
analytical challenges, increasing productivity in their
laboratories, improving patient health through diagnostics or the
development and manufacture of life-changing therapies, we are here
to support them. Our global team delivers an unrivaled combination
of innovative technologies, purchasing convenience and
pharmaceutical services through our industry-leading brands,
including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher
Scientific, Unity Lab Services, Patheon and PPD. For more
information, please visit www.thermofisher.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221110006109/en/
Media Contact Information: Sandy Pound 781-622-1223
sandy.pound@thermofisher.com
Investor Contact Information: Rafael Tejada 781-622-1356
rafael.tejada@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024